Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA480495
Max Phase: Preclinical
Molecular Formula: C23H45N7O9
Molecular Weight: 563.65
Molecule Type: Protein
Associated Items:
ID: ALA480495
Max Phase: Preclinical
Molecular Formula: C23H45N7O9
Molecular Weight: 563.65
Molecule Type: Protein
Associated Items:
Canonical SMILES: C[C@@H](O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O
Standard InChI: InChI=1S/C23H45N7O9/c1-12(32)17(30-22(37)18(13(2)33)29-19(34)14(26)7-3-5-9-24)21(36)27-15(8-4-6-10-25)20(35)28-16(11-31)23(38)39/h12-18,31-33H,3-11,24-26H2,1-2H3,(H,27,36)(H,28,35)(H,29,34)(H,30,37)(H,38,39)/t12-,13-,14+,15+,16+,17+,18+/m1/s1
Standard InChI Key: LDWBQGACJJOIKA-RHEFHGCGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 563.65 | Molecular Weight (Monoisotopic): 563.3279 | AlogP: -4.65 | #Rotatable Bonds: 20 |
Polar Surface Area: 292.45 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.29 | CX Basic pKa: 12.82 | CX LogP: -7.89 | CX LogD: -10.76 |
Aromatic Rings: 0 | Heavy Atoms: 39 | QED Weighted: 0.06 | Np Likeness Score: 0.58 |
1. Choi HI, Kim HJ, Park JI, Shin EH, Kim DW, Kim SS.. (2009) Design and efficient synthesis of novel ascorbyl conjugated peptide with high collagen biosynthesis stimulating effects., 19 (7): [PMID:19268583] [10.1016/j.bmcl.2008.10.112] |
2. Lu C, Kim BM, Lee D, Lee MH, Kim JH, Pyo HB, Chai KY.. (2013) Synthesis of lipoic acid-peptide conjugates and their effect on collagen and melanogenesis., 69 [PMID:24090916] [10.1016/j.ejmech.2013.09.011] |
Source(1):